Related Experiment Videos
Two-dimensional and three-dimensional oxygen mapping by 3He-MRI validation in a lung phantom.
Klaus Kurt Gast1, Wolfgang G Schreiber, Annette Herweling
1Department of Radiology, Johannes Gutenberg University Hospital, Langenbeckstrasse 1, 55131, Mainz, Germany. kgast@radiologie.klinik.uni-mainz.de
European Radiology
|April 28, 2005
Summary
Oxygen-sensitive Helium-3 Magnetic Resonance Imaging (3He-MRI) accurately maps oxygen partial pressure distribution in lung phantoms. This noninvasive technique shows strong correlation with traditional gas analysis for regional oxygenation assessment.
Area of Science:
- Medical Imaging
- Pulmonary Physiology
- Magnetic Resonance Imaging
Background:
- Accurate assessment of regional oxygen partial pressure is crucial for diagnosing and managing respiratory diseases.
- Current methods for measuring oxygen distribution can be invasive or lack detailed spatial resolution.
Purpose of the Study:
- To validate the use of oxygen-sensitive Helium-3 Magnetic Resonance Imaging (3He-MRI) for noninvasive, quantitative mapping of oxygen partial pressure.
- To assess the accuracy of 3He-MRI in determining regional, two- and three-dimensional oxygen distribution in a lung phantom model.
Main Methods:
- Oxygen-sensitive 3He-MRI measurements were conducted on a silicon lung phantom at various oxygen concentrations.
- Newly developed software was used to map oxygen partial pressure from 3He-MRI data.
- Reference bulk oxygen partial pressure was measured using conventional respiratory gas analysis.
Main Results:
- High correlation (r=0.98 for 2D, r=0.89 for 3D) was observed between 3He-MRI and gas analysis for oxygen partial pressure.
- The signal-to-noise ratio in 3D 3He-MRI was approximately half that of 2D measurements, becoming critical in some datasets.
Conclusions:
- Oxygen-sensitive 3He-MRI is a validated, noninvasive method for determining the two- and three-dimensional distribution of oxygen partial pressure in gas-filled airspaces.
- This technique holds promise for improved diagnostic capabilities in pulmonary medicine.